Perifollicular repigmentation was observed in 82.8% of cases in the drug group versus 75.9% in the placebo group, although this difference did not reach statistical significance.
← all excerpts
Phototherapy with Topical Minoxidil in Vitiligo: A Randomized Control Trial.
1
—
—